MedTrace Logo

Effect of Nephral 400 ST Dialysis Membrane on Coagulation in Hemodialysis

NCT00594607 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2011-07-06

No results posted yet for this study

Summary

The purpose of this study is to investigate whether the dialysis filter AN69ST (Nephral 400 ST Dialysis Membrane) induces less clotting during hemodialysis than a conventional polysulphone filter. Our hypothesis is that the two filters induce the same degree of clotting.

Conditions

  • Extracorporeal Clotting During Hemodialysis

Interventions

DEVICE

AN69ST dialysis membrane

AN69ST is the filter that the blood goes through during hemodialysis

DEVICE

Fx8 (Fresenius)

Polysulphone dialysis membrane

Sponsors & Collaborators

  • Rikshospitalet University Hospital

    collaborator OTHER

  • Ullevaal University Hospital

    lead OTHER

Principal Investigators

  • Solbjørg Sagedal, PhD, MD · Department of Nephrology, Ullevål University hospital, 0407 Oslo

  • Anders Hartmann, PhD, MD · Department of Internal medicine, Rikshospitalet University Hospital, 0027 Oslo

  • Solbjørg Sagedal, PhD, MD · department of Nephrology, Ullevål University Hospital, Oslo

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-09-30
Primary Completion
2008-05-31
Completion
2008-05-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00594607 on ClinicalTrials.gov